Effectiveness and Cost-effectiveness of Community-based Directly Observed Treatment (DOT) Versus Health Facility-based DOT of Tuberculosis in Africa: Protocol for a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 May 9

PMID 38724061

Authors

Tenaw Baye

Abebe Tarekegn Kassaw

Desye Gebrie

Fentaw Girmaw

Getachew Ashagrie

Affiliations

Soon will be listed here.

Abstract

Background: Tuberculosis (TB) remains a significant global health challenge, especially prevalent in the WHO African region. The WHO's End TB Strategy emphasises effective treatment approaches such as directly observed therapy (DOT), yet the optimal implementation of DOT, whether through health facility-based (HF DOT) or community-based (CB DOT) approaches, remains uncertain.

Objective: To conduct a systematic comparison of the effectiveness and cost-effectiveness of Community-Based Directly Observed Treatment (CB DOT) versus Health Facility-Based Directly Observed Treatment (HF DOT) for tuberculosis (TB) treatment in African settings.

Methods: We will conduct a systematic review and meta-analysis following Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines. We will search PubMed, Embase, Web of Science, Scopus and the Cochrane Library for articles published up to 30 March 2023, without date restrictions. Eligible studies must be full economic evaluations conducted in African countries, comparing CB DOT to HF DOT regarding treatment outcomes and costs. Exclusion criteria include non-English, non-peer-reviewed or studies lacking caregiver involvement in CB DOT, health facility-based DOT comparison, direct comparability between CB DOT and HF DOT, significant selection bias or non-economic evaluations. Data extraction will be performed independently by reviewers, and meta-analyses will use STATA software. To pool the data, a random-effect model will be applied, and quality assessment of the studies will be conducted.

Ethics And Dissemination: Ethical approval is not required as the study will use previously published articles available publicly. Findings will be presented at international and national conferences and published in open-access, peer-reviewed journals.

Prospero Registration Number: CRD42023443260.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, Aponte J . Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health. 2003; 8(3):204-10. DOI: 10.1046/j.1365-3156.2003.00999.x. View

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

Khan M, Walley J, Witter S, Imran A, Safdar N . Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment. Health Policy Plan. 2002; 17(2):178-86. DOI: 10.1093/heapol/17.2.178. View

Wandwalo E, Makundi E, Hasler T, Morkve O . Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban setting. Health Policy. 2005; 78(2-3):284-94. DOI: 10.1016/j.healthpol.2005.11.010. View

Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D . Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S56-62. View

Wright C, Westerkamp L, Korver S, Dobler C . Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness. BMC Infect Dis. 2015; 15:210. PMC: 4436810. DOI: 10.1186/s12879-015-0945-5. View

Bayer R, Wilkinson D . Directly observed therapy for tuberculosis: history of an idea. Lancet. 1995; 345(8964):1545-8. DOI: 10.1016/s0140-6736(95)91090-5. View

Zvavamwe Z, Ehlers V . Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study. Int J Nurs Stud. 2008; 46(3):302-9. DOI: 10.1016/j.ijnurstu.2008.09.013. View

10.

Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, Kenyon T . Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S80-5. View

11.

Maher D, Hausler H, Raviglione M, Kaleeba N, Aisu T, Fourie B . Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis. 1997; 1(3):276-83. View

12.

Wandwalo E, Robberstad B, Morkve O . Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Eff Resour Alloc. 2005; 3:6. PMC: 1180840. DOI: 10.1186/1478-7547-3-6. View

13.

Datiko D, Lindtjorn B . Cost and cost-effectiveness of smear-positive tuberculosis treatment by Health Extension Workers in Southern Ethiopia: a community randomized trial. PLoS One. 2010; 5(2):e9158. PMC: 2822844. DOI: 10.1371/journal.pone.0009158. View

14.

Okello D, Floyd K, Adatu F, Odeke R, Gargioni G . Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S72-9. View

15.

Nganda B, Wangombe J, Floyd K, Kangangi J . Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S14-20. View

16.

Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F . Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis. 2003; 7(9 Suppl 1):S29-37. View

17.

Kamolratanakul P, Sawert H, Lertmaharit S, Kasetjaroen Y, Akksilp S, Tulaporn C . Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg. 2000; 93(5):552-7. DOI: 10.1016/s0035-9203(99)90379-6. View

18.

Husereau D, Drummond M, Augustovski F, De Bekker-Grob E, Briggs A, Carswell C . Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value Health. 2022; 25(1):10-31. DOI: 10.1016/j.jval.2021.10.008. View

19.

Steffen R, Menzies D, Oxlade O, Pinto M, Castro A, Monteiro P . Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil. PLoS One. 2010; 5(11):e14014. PMC: 2984447. DOI: 10.1371/journal.pone.0014014. View

20.

Zhang H, Ehiri J, Yang H, Tang S, Li Y . Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(2):e0147744. PMC: 4744041. DOI: 10.1371/journal.pone.0147744. View